AIM ImmunoTech Inc. (AIM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.61
-0.04 (-1.51%)
At close: Oct 03, 2025, 3:59 PM
2.73
4.48%
After-hours: Oct 03, 2025, 07:49 PM EDT

AIM ImmunoTech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
25K 16K 45K 35K 50K 40K 65K 46K 42K 49K 56K 21K 30K 33K 50K 33K 23K 28K
Cost of Revenue
10K 10K -51K 8K 8K 66K 70K 30K 91K 84K n/a 6.52M 69K 77K 176K 157K 279K 237K
Gross Profit
15K 6K 96K 27K 42K -26K -5K 16K -49K -35K 56K -6.5M -39K -44K -126K -124K -256K -209K
Operating Income
-2.65M -3.62M -5.86M -4.49M -3.69M -5.73M -13.99M -7.82M -5.46M -4.29M -5.56M -6.52M -4.7M -3.15M -7.45M -3.93M -3.72M -3.75M
Interest Income
10K 11K 1.81M 718K 2.58M 81K 258K 294K 318K 199K 333K 172K 79K 45K n/a n/a 51K 72K
Pretax Income
-2.79M -3.71M -5.97M -3.7M -1.84M -5.82M -12.58M -7.82M -4.91M -3.66M -4.39M -6.38M -4.85M -3.82M -5.85M -3.83M -5.88M -3.58M
Net Income
-2.79M -3.71M -5.97M -3.7M -1.84M -5.82M -12.58M -7.82M -4.91M -2.85M -4.39M -6.25M -5.01M -4.49M -5.85M -3.83M -5.88M -3.58M
Selling & General & Admin
1.49M 2.54M 4.29M 3.08M 2.59M 3.76M 10.8M 5.44M 2.55M 2.29M 3.5M 5.17M 2.18M 2.07M 2.62M 1.8M 2.15M 2.11M
Research & Development
1.17M 1.08M 1.66M 1.44M 1.15M 1.95M 3.19M 2.73M 2.95M 2.05M 2.11M 1.37M 2.48M 1.04M 2.92M 2.01M 1.32M 1.42M
Other Expenses
n/a n/a n/a n/a n/a n/a 15K n/a 328K 255K n/a 328K n/a n/a n/a n/a n/a n/a
Operating Expenses
2.66M 3.63M 5.95M 4.52M 3.74M 5.71M 13.98M 8.17M 5.5M 4.34M 5.61M 6.54M 4.66M 3.11M 5.54M 3.81M 3.46M 3.54M
Interest Expense
149K 124K 132K 202K 179K 72K 634K n/a n/a n/a n/a n/a n/a n/a n/a 20K 19K 50K
Selling & Marketing Expenses
n/a n/a 58K n/a n/a -58K 67K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.67M 3.63M 5.9M 4.52M 3.74M 5.77M 14.05M 8.2M 5.5M 4.34M 5.61M 6.54M 4.72M 3.19M 5.72M 3.96M 3.74M 3.77M
Income Tax Expense
n/a n/a n/a n/a n/a 14.72K n/a -6K n/a -814K n/a -136K 156K 668K n/a n/a n/a n/a
Shares Outstanding (Basic)
759.29K 70.33M 56.85M 57.68M 52.84M 49.46M 49.1M 48.64M 48.41M 48.4M 48.22M 48.08M 48.03M 47.99M 47.85M 47.85M 47.83M 45.73M
Shares Outstanding (Diluted)
759.29K 70.33M 56.85M 57.68M 52.84M 49.46M 49.1M 48.64M 48.41M 48.4M 48.22M 48.08M 48.03M 47.99M 47.85M 47.85M 47.83M 45.73M
EPS (Basic)
-3.68 -0.05 -0.1 -0.06 -0.03 -0.12 -0.26 -0.16 -0.1 -0.06 -0.09 -0.13 -0.1 -0.09 -0.12 -0.08 -0.12 -0.08
EPS (Diluted)
-3.68 -0.05 -0.1 -0.06 -0.03 -0.12 -0.26 -0.16 -0.1 -0.06 -0.09 -0.13 -0.1 -0.09 -0.12 -0.08 -0.12 -0.08
EBITDA
-2.59M -3.46M -5.77M -3.44M -1.6M -5.69M -13.95M -8.1M -4.82M -3.58M -4.22M -6.49M -4.82M -3.12M -5.66M -3.64M -5.67M -3.29M
EBIT
-2.65M -3.58M -5.83M -3.5M -1.66M -5.75M -14M -8.16M -4.91M -3.66M -4.39M -6.52M -4.85M -3.15M -5.85M -3.81M -5.86M -3.53M
Depreciation & Amortization
55K 122K 64K 63K 61K 58K 58K 53K 91K 84K 170K 51K 29K 34K 189K 189K 189K 238K